Mutation | Genotype | Frequency | Clinical importance | References for associated clinical significance |
S207N | A | 53 | Immune escape, HbsAg detection failure, Increased HBsAg reactivity in immunological diagnostic assays, causes hepatocellular carcinoma/cirrhosis and is an asymptomatic carrier | [13] [15] |
A194V | A | 36 | Immune escape, Drug (tenofovir) resistance and others | [2] [16] |
A194V | D | 4 | Immune escape, Drug (tenofovir) resistance and others | [2] [16] |
K122R | A, D | 14 | Immune escape and is an occult infection related mutation | [15] [17] |
T114S | A, D | 12 | Causes immunosuppression and HBV reactivation | [18] |
V168A | A, D | 11 | Detection failure and is a occult infection related mutations | [17] |
N131T | A, D | 7 | Immune escape | [15] [19] |
Y161F7 | A | 7 | Immune escape | [15] |
N40S | A | 6 | Reduced HBsAg detection signals | [15] |
I68T | A | 6 | Hepatocellular carcinoma (HCC) | [15] [19] |
T143S | A | 6 | Immune escape, Vaccine escape, HBIg therapy escape, detection failure of HbsAg and alter the antigenic properties of variant HBsAg | [15] [20] [21] |
A159G | A | 6 | Immune escape | [15] [19] |
S45T5/A5 | A | 5.5 | Reduced HBsAg detection signals | [15] [19] |
P46T5 | A |
| Reduced HBsAg detection signals | [15] |
C76Y5 | A |
| Immune escape (detection failure) and causes Hepatocellular carcinoma/cirrhosis and is an asymptomatic carrier | [15] [21] |